RG PHARMA LTDActive
Key figures
Like most small UK companies, RG PHARMA LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025/26Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £500.
Filed accounts2023/24–2025/26
| 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|
| Cash at bank and in hand | 4,512 | 2,136 | 11,060 |
| Total assets | 4,512 | 3,269 | 11,375 |
| Total liabilities | 1,495 | 1,582 | 3,030 |
| Net assets / total equity | 3,017 | 1,687 | 8,345 |
| Average number of employees | 1 | 1 | 1 |
| Dividends paid | 1,000 | 0 | 500 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2026The principal activity of the company during the year under review was the provision of other professional, scientific and technical activities not elsewhere classified.
As described in the company's latest filed accounts.
Summary: RG PHARMA LTD
Company
RG PHARMA LTD is a private limited company registered with Companies House under company number 14798155. It was incorporated on 13 Apr 2023. Its status is active. The registered office is in Milton keynes (MK17). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).
Accounts
The latest accounts in the database are for 2025/26 (period ending 30 Apr 2026); the company files small company accounts (filleted). Net assets were £8,345, up 394.7% on the previous year. Cash at bank and in hand was £11,060. Total assets were £11,375 and total liabilities £3,030. The company had an average of 1 employee. Figures are available for 3 financial years (2023/24–2025/26).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Jan 2028. The next confirmation statement is due by 26 Apr 2027.